Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-013417
Filing Date
2020-05-18
Accepted
2020-05-18 17:41:38
Documents
1
Period of Report
2020-05-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6473
  Complete submission text file 0000899243-20-013417.txt   7925
Mailing Address 17 STATE STREET 7TH FLOOR NEW YORK NY 10004
Business Address 17 STATE STREET 7TH FLOOR NEW YORK NY 10004 212-461-2315
TYME TECHNOLOGIES, INC. (Issuer) CIK: 0001537917 (see all company filings)

EIN.: 453864597 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address 44 WALL STREET, 12TH FLOOR NEW YORK NY 10005
Business Address
Eckard Jonathan (Reporting) CIK: 0001723096 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38169 | Film No.: 20890942